Resolving Allergies through Immunomodulation
How We Reset Overactive Immune Responses via the JAK1/TYK2 Pathway and the Microbiome
Moving beyond the temporary blocking of histamine—stopping the allergic cascade directly at its genetic source. Lyophilization (freeze-drying) technology applied to combat food, respiratory, and drug hypersensitivities.
Why Do Allergies Keep Coming Back? Beyond Histamine
Allopathic medicine addresses allergies (whether food-related, respiratory, or cutaneous) by administering antihistamines or corticosteroids. These treatments offer only temporary relief: they attempt to intercept histamine after mast cells have already been activated, triggering inflammation, itching, and edema. Furthermore, severe allergic reactions—such as anaphylactic shock or glottal edema—remain major, unpredictable risks.
The **Alergiplant biomedical platform** takes a radically different approach by targeting the molecular root cause. Excessive allergic reactions are governed upstream by inflammatory cytokines that utilize the **JAK1/TYK2** signaling pathway to instruct B lymphocytes to produce an overabundance of IgE antibodies. By employing polyphenolic matrices derived from freeze-dried plants, we achieve **asymmetric and selective inhibition**. These natural compounds act as a precise “brake” on the JAK1/TYK2 axis, preventing mast cells from receiving the signal to degranulate and release histamine.
The Microbiome-Lung-Skin Axis: The Epigenetic Mechanism of Allergic Reset
A food, respiratory, or drug allergy always indicates a compromised biological barrier (“leaky gut”) and profound dysbiosis. The immune reset circuit operates systemically:
1. Restoring eubiosis in barrier microbiotas
The pure, natural ligands introduced via our lyophilized (freeze-dried) formulas act simultaneously on the intestinal, respiratory, and cutaneous microbiomes, eliminating opportunistic strains that keep the immune system in a state of false alert.
2. Synthesis of protective metabolites (SCFAs)
Thanks to the micro-porosity achieved through the industrial lyophilization process, the compounds are rapidly digested by commensal bacteria, resulting in a massive secretion of butyrate. This restores the tight junctions of the mucous membranes, preventing allergenic macromolecules from passing into the bloodstream.
3. Epigenetic reprogramming of tolerance
Microbial metabolites act directly on histones within T cells, signaling the cessation of aberrant IgE production. The immune system learns to tolerate pollen, dust, or specific foods once again, eliminating contact reactivity.
The Transition from Infusion to Alergiplant Nanomedicine
For decades, the Alergiplant herbal tea formula has demonstrated—through observational studies involving thousands of cases—that the human body can be completely desensitized. Individuals suffering from severe allergies to ragweed, dust, animal dander, or certain foods have been able to return to a normal life, gradually reintroducing problematic foods into their diets. Research conducted at the Deniplant Center for Biomedicine, in collaboration with Prof. Dr. Manole Cojocaru, confirms this process of homeostatic regulation.
Through our new technological initiative—shifting toward high-purity lyophilized extracts (natural botanical nanoparticles)—we have eliminated all barriers to administration:
Freeze-drying at -40°C isolates the active principles found in flowers, fruit tree buds, and wild flora, all while preserving their immunomodulatory properties. Patients receive an instantly soluble powder that delivers an optimal concentration of JAK1/TYK2 inhibitors. These compounds are capable of halting allergic inflammation and providing long-term safety, with zero risk of the drowsiness or dependency often associated with allopathic medications.